Endocannabinoid System and Cannabinoid 1 Receptors in Patients With Pharmacoresistant Temporal Lobe Epilepsy and Comorbid Mood Disorders

Experimental evidence points out that the activation of the endocannabinoid system induces neuroprotective effects and reduces mood disorders. In the hippocampus of patients with mesial temporal lobe epilepsy (MTLE), studies indicated augmented cannabinoid 1 receptor (CB(1)R) binding, in spite of it...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocha, Luisa, Cinar, Resat, Guevara-Guzmán, Rosalinda, Alonso-Vanegas, Mario, San-Juan, Daniel, Martínez-Juárez, Iris, Castañeda-Cabral, José Luis, Carmona-Cruz, Francia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218130/
https://www.ncbi.nlm.nih.gov/pubmed/32435186
http://dx.doi.org/10.3389/fnbeh.2020.00052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218130/
https://www.ncbi.nlm.nih.gov/pubmed/32435186
http://dx.doi.org/10.3389/fnbeh.2020.00052

Ejemplares similares